The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival

Y. A. Valentin-Vega, Hideyuki Okano, G. Lozano

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Mdm2 is the major inhibitor of the p53 tumor suppressor. Loss of Mdm2 in mice or in specific tissues of the mouse always yields p53-dependent lethal phenotypes. However, the role of Mdm2 in tissues with high turnover capacity is unknown. We have engineered mice lacking Mdm2 in the intestinal epithelium using the Cre/LoxP system. Loss of Mdm2 (Mdm2intΔ) results in viable animals, but neonates display multiple intestinal abnormalities such as hyperplasia, enterocyte vacuolization, and inflammation. These defects correlate with a drastic increase in p53-dependent apoptosis in highly proliferative and differentiated cells. Unexpectedly, the observed phenotypes disappear with age. The tissue selects against Mdm2-null cells and increases its proliferative capacity. Additionally, the intestinal stem and progenitor cell populations are enriched leading to an increase in crypt fission events. Enhanced proliferation is achieved by activation of the canonical Wnt and EGFR-mediated Ras/MAPK pathways. While Mdm2 is a critical inhibitor of p53 in the intestinal epithelium, the tissue employs a series of processes that compensate for cell death.

Original languageEnglish
Pages (from-to)1772-1781
Number of pages10
JournalCell Death and Differentiation
Volume15
Issue number11
DOIs
Publication statusPublished - 2008

Fingerprint

Intestinal Mucosa
Cell Death
Stem Cells
Multiple Abnormalities
Phenotype
Null Lymphocytes
Enterocytes
Hyperplasia
Apoptosis
Inflammation
Population
Neoplasms

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival. / Valentin-Vega, Y. A.; Okano, Hideyuki; Lozano, G.

In: Cell Death and Differentiation, Vol. 15, No. 11, 2008, p. 1772-1781.

Research output: Contribution to journalArticle

@article{be1e07cd5ca440c0994e52ef50d90f87,
title = "The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival",
abstract = "Mdm2 is the major inhibitor of the p53 tumor suppressor. Loss of Mdm2 in mice or in specific tissues of the mouse always yields p53-dependent lethal phenotypes. However, the role of Mdm2 in tissues with high turnover capacity is unknown. We have engineered mice lacking Mdm2 in the intestinal epithelium using the Cre/LoxP system. Loss of Mdm2 (Mdm2intΔ) results in viable animals, but neonates display multiple intestinal abnormalities such as hyperplasia, enterocyte vacuolization, and inflammation. These defects correlate with a drastic increase in p53-dependent apoptosis in highly proliferative and differentiated cells. Unexpectedly, the observed phenotypes disappear with age. The tissue selects against Mdm2-null cells and increases its proliferative capacity. Additionally, the intestinal stem and progenitor cell populations are enriched leading to an increase in crypt fission events. Enhanced proliferation is achieved by activation of the canonical Wnt and EGFR-mediated Ras/MAPK pathways. While Mdm2 is a critical inhibitor of p53 in the intestinal epithelium, the tissue employs a series of processes that compensate for cell death.",
author = "Valentin-Vega, {Y. A.} and Hideyuki Okano and G. Lozano",
year = "2008",
doi = "10.1038/cdd.2008.109",
language = "English",
volume = "15",
pages = "1772--1781",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival

AU - Valentin-Vega, Y. A.

AU - Okano, Hideyuki

AU - Lozano, G.

PY - 2008

Y1 - 2008

N2 - Mdm2 is the major inhibitor of the p53 tumor suppressor. Loss of Mdm2 in mice or in specific tissues of the mouse always yields p53-dependent lethal phenotypes. However, the role of Mdm2 in tissues with high turnover capacity is unknown. We have engineered mice lacking Mdm2 in the intestinal epithelium using the Cre/LoxP system. Loss of Mdm2 (Mdm2intΔ) results in viable animals, but neonates display multiple intestinal abnormalities such as hyperplasia, enterocyte vacuolization, and inflammation. These defects correlate with a drastic increase in p53-dependent apoptosis in highly proliferative and differentiated cells. Unexpectedly, the observed phenotypes disappear with age. The tissue selects against Mdm2-null cells and increases its proliferative capacity. Additionally, the intestinal stem and progenitor cell populations are enriched leading to an increase in crypt fission events. Enhanced proliferation is achieved by activation of the canonical Wnt and EGFR-mediated Ras/MAPK pathways. While Mdm2 is a critical inhibitor of p53 in the intestinal epithelium, the tissue employs a series of processes that compensate for cell death.

AB - Mdm2 is the major inhibitor of the p53 tumor suppressor. Loss of Mdm2 in mice or in specific tissues of the mouse always yields p53-dependent lethal phenotypes. However, the role of Mdm2 in tissues with high turnover capacity is unknown. We have engineered mice lacking Mdm2 in the intestinal epithelium using the Cre/LoxP system. Loss of Mdm2 (Mdm2intΔ) results in viable animals, but neonates display multiple intestinal abnormalities such as hyperplasia, enterocyte vacuolization, and inflammation. These defects correlate with a drastic increase in p53-dependent apoptosis in highly proliferative and differentiated cells. Unexpectedly, the observed phenotypes disappear with age. The tissue selects against Mdm2-null cells and increases its proliferative capacity. Additionally, the intestinal stem and progenitor cell populations are enriched leading to an increase in crypt fission events. Enhanced proliferation is achieved by activation of the canonical Wnt and EGFR-mediated Ras/MAPK pathways. While Mdm2 is a critical inhibitor of p53 in the intestinal epithelium, the tissue employs a series of processes that compensate for cell death.

UR - http://www.scopus.com/inward/record.url?scp=54049109574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049109574&partnerID=8YFLogxK

U2 - 10.1038/cdd.2008.109

DO - 10.1038/cdd.2008.109

M3 - Article

C2 - 18636077

AN - SCOPUS:54049109574

VL - 15

SP - 1772

EP - 1781

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 11

ER -